Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.31 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.31 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.31 |
| ▸ | ITGAL | P20701 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2965295 | 1.00 | KDM4E (0.36) | KDM4EMEN1ALDH1A1MAPTKMT2A | |
| Hydrochloric Acid SCHEMBL11520833 | 0.98 | KDM4E (0.35) | KDM4EMEN1ALDH1A1MAPTKMT2A | |
| Hydrochloric Acid SCHEMBL8071921 | 0.98 | KDM4E (0.35) | KDM4EMEN1ALDH1A1MAPTKMT2A | |
| Cyclohexane SCHEMBL23674788 | 0.93 | KDM4E (0.33) | KDM4EMEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL23674717 | 0.84 | LMNA (0.36) | ITGB2ICAM1ITGAL | |
| 2,3,7,8-Tetrachlorodibenzo-P-Dioxin SCHEMBL10692049 | 0.83 | AHR (0.45) | KDM4EMEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL8029525 | 0.82 | CTSD (0.33) | KDM4EMEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL630371 | 0.76 | — | — | |
| SCHEMBL231835 | 0.76 | KDM4E (0.34) | KDM4EMEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL3556 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1909 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12548798-B2 | Hydrofluorocarbon (HFC)-based safe electrolyte for secondary batteries | BATTELLE MEMORIAL INSTITUTE (US) | 2026-02-10 | — | — | US | claimed |
| WO-2025105341-A1 | METAL PATTERNING MATERIAL, PENTAFLUOROSULFANYL COMPOUND, METAL PATTERNING THIN FILM, ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC APPARATUS, AND METAL PATTERN FORMING METHOD | 東ソー株式会社 | 2025-05-22 | — | — | WO | claimed |
| US-20250154114-A1 | MATERIAL FOR METAL PATTERNING, HETEROCYCLIC COMPOUND, THIN FILM FOR METAL PATTERNING, ORGANIC ELECTROLUMINESCENT DEVICE, ELECTRONIC DEVICE, AND METHOD FOR FORMING METAL PATTERN | TOSOH CORPORATION (JP) | 2025-05-15 | — | — | US | claimed |
| WO-2025028487-A1 | MATERIAL FOR METAL PATTERNING, HETEROCYCLIC COMPOUND, THIN FILM FOR METAL PATTERNING, ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND METHOD FOR FORMING METAL PATTERN | 東ソー株式会社 | 2025-02-06 | — | — | WO | claimed |
| EP-3885337-B1 | FTO INHIBITORS | NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING (CN) | 2025-01-15 | — | — | EP | claimed |
| WO-2024248132-A1 | METAL PATTERNING MATERIAL, HETEROCYCLIC COMPOUND, THIN FILM FOR METAL PATTERNING, ORGANIC ELECTROLUMINESCENCE ELEMENT, ELECTRONIC APPARATUS, AND METAL PATTERN FORMATION METHOD | 東ソー株式会社 | 2024-12-05 | — | — | WO | claimed |
| CN-118696625-A | Material for metal patterning, heterocyclic compound, thin film for metal patterning, organic electroluminescent element, electronic device, and method for forming metal pattern | 东曹株式会社 | 2024-09-24 | — | — | CN | claimed |
| CN-114805163-B | Method for synthesizing organic selenium compound | 西南石油大学 | 2024-06-21 | — | — | CN | claimed |
| WO-2024128829-A1 | TRAP-1 INHIBITOR | 주식회사 스마틴바이오 | 2024-06-20 | — | — | WO | claimed |
| EP-3652180-B1 | SUBSTITUTED BENZOXAZOLE AND BENZOFURAN COMPOUNDS AS PDE7 INHIBITORS | DART NEUROSCIENCE LLC (US) | 2023-11-29 | — | — | EP | claimed |
| EP-0624582-A1 | Substituted benzodioxine, process for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1994-11-17 | — | — | EP | claimed |
| US-5332563-A | Detoxification of chemicals by oxidation with air to produce phosphorous oxide or phosphoric acid and reaction with organic compounds, degassing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-07-26 | — | — | US | claimed |
| EP-0537519-A1 | Method for the preparation of fluoro substituted aminobenzodioxoles and -benzodioxanes and intermediates | BAYER AG (DE) | 1993-04-21 | — | — | EP | claimed |
| EP-0532100-A1 | Benzodioxinopyrrole derivative as alpha 2-adrenoreceptor antagonist | GLAXO GROUP LIMITED (GB) | 1993-03-17 | — | — | EP | claimed |
| CN-1053607-A | The human immunity that is used for the treatment of AIDS lacks the inhibitor of virus protease | MERCK & CO INC (US) | 1991-08-07 | — | — | CN | claimed |
| US-4613601-A | (1-benzodioxin-6-ylmethyl)-4-substituted piperazines having antipsychotic activity | ADIR, S.A.R.L. (FR) | 1986-09-23 | — | — | US | claimed |
| EP-0104529-B1 | CATIONIC DYES, THEIR PREPARATION AND THEIR USE IN DYEING SYNTHETIC AND NATURAL MATERIAL | BAYER AG (DE) | 1986-03-05 | — | — | EP | claimed |
| EP-0084993-B1 | BENZODIOXINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ADIR (FR) | 1985-07-24 | — | — | EP | claimed |
| EP-0084993-A2 | Benzodioxine derivatives, processes for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1983-08-03 | — | — | EP | claimed |
| EP-0018675-A2 | Lipogenesis inhibiting composition and process for its preparation | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1980-11-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250154114-A1 | MATERIAL FOR METAL PATTERNING, HETEROCYCLIC COMPOUND, THIN FILM FOR METAL PATTERNING, ORGANIC ELECTROLUMINESCENT DEVICE, ELECTRONIC DEVICE, AND METHOD FOR FORMING METAL PATTERN | NES, L1CAM, MNS1 | KDM4E 3270/4885MEN1 257/4885ALDH1A1 658/4885 |
| US-12548798-B2 | Hydrofluorocarbon (HFC)-based safe electrolyte for secondary batteries | SLC9A2, SLC9A1, SLC9A3 | KDM4E 1022/4885MEN1 3665/4885ALDH1A1 3401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.